Global birth prevalence of galactosemia and the role of neonatal screening: A scoping review
Authors:
- Augusto Vargas PessiAPAugusto Vargas Pessi
- Vivian de Lima Spode CoutinhoVCVivian de Lima Spode Coutinho
- Bruna Bento dos SantosBSBruna Bento dos Santos
- Ida Vanessa Doederlein SchwartzISIda Vanessa Doederlein Schwartz
- Liane Nanci RottaLiane Nanci Rotta
Open Access
- 8 August 2026
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 149 (1-2)
Abstract
No abstract availableFunding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 36 references indexed in Scilit:
- Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular modelsJournal of Inherited Metabolic Disease, 2019
- Sweet and sour: an update on classic galactosemiaJournal of Inherited Metabolic Disease, 2017
- Newborn screening for galactosemia: a 30-year single center experienceWorld Journal of Pediatrics, 2015
- Features and outcome of galactokinase deficiency in children diagnosed by newborn screeningJournal of Inherited Metabolic Disease, 2011
- Galactosaemia in a Brazilian population: High incidence and cost–benefit analysisJournal of Inherited Metabolic Disease, 2009
- Neonatal screening in Europe; the situation in 2004Journal of Inherited Metabolic Disease, 2007
- Large-scale molecular screening for galactosemia alleles in a pan-ethnic populationHuman Genetics, 2001
- Measurements of uridine diphosphate glucose and uridine diphosphate galactose — an appraisalEuropean Journal of Pediatrics, 1995
- Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West GermanyEuropean Journal of Pediatrics, 1986
- Galactosaemia: Estimated live birth incidence in New ZealandHuman Genetics, 1975